Currently claims are being reviewed regarding women who used talc powder near their private areas and have developed cancer in their ovaries. Many studies done since 1971, have linked this type of powder and ovarian cancer. A landmark study done in 1982 showed that women were at a 92 percent increased risk of developing ovarian cancer when they used this product as personally as Johnson and Johnson marketed it to be used.
Researchers, alarmed by the results of this study, recommended that Johnson and Johnson immediately provide consumers with a warning about this risk on it’s packaging for the powder; more than 30 years later and Johnson and Johnson has yet to comply to that request. There is still no warning concerning the risk for ovarian cancer on their packaging.
It is believed that talc powder, even when used externally in a personal area, can migrate up into the ovaries and over time become fused to the tissue. It is not a simple process for the body to naturally remove talc eventually resulting in the ovaries becoming inflamed and in worst case scenarios, malignant tumors can form.
Johnson & Johnson is now facing a class action talcum powder lawsuit claiming that they failed to alert women to the high risks of ovarian cancer associated with the personal use of talc powder products.
Regrettably, it is noted that the only compensation one can hope to gain from this claim is the cost of the powder products. Whether or not these women developed ovarian cancer is irrelevant to Johnson and Johnson.
Sadly, it is said Johnson & Johnson, the maker of the most popular talcum powders, including Baby Powder and Shower-to-Shower, were well aware of the high risks associated with talc powder since 1982, but failed to adequately label these products, especially for the personal use in which they advertised their product for.